Skip to main content
Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · IEX Real-Time Price · USD
2.330
+0.160 (7.37%)
At close: May 1, 2024, 4:00 PM
2.220
-0.110 (-4.72%)
After-hours: May 1, 2024, 6:21 PM EDT

Lyell Immunopharma Market Cap

Lyell Immunopharma has a market cap or net worth of $594.00 million as of May 1, 2024. Its market cap has increased by 23.31% in one year.

Market Cap
594.00M
Enterprise Value
104.39M
1-Year Change
23.31%
Ranking
#2815
Category
Small-Cap
Stock Price
$2.33

Market Cap Chart

Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $594.00M, a decrease of -85.61%. That is a compound annual growth rate of -49.06%.

History

DateMarket Cap% Change
May 1, 2024592.00M7.36%
Apr 30, 2024551.40M-3.55%
Apr 29, 2024571.70M3.68%
Apr 26, 2024551.40M-1.36%
Apr 25, 2024559.00M-4.35%
Apr 24, 2024584.40M-5.74%
Apr 23, 2024620.00M1.24%
Apr 22, 2024612.40M8.08%
Apr 19, 2024566.60M-4.29%
Apr 18, 2024592.00M-2.10%
Apr 17, 2024604.70M-1.26%
Apr 16, 2024612.40M0.43%
Apr 15, 2024609.80M-20.27%
Apr 12, 2024764.80M13.15%
Apr 11, 2024675.90M8.58%
Apr 10, 2024622.50M-2.78%
Apr 9, 2024640.30M15.06%
Apr 8, 2024556.50M4.78%
Apr 5, 2024531.10M-
Apr 4, 2024531.10M1.47%
Apr 3, 2024523.40M-0.97%
Apr 2, 2024528.50M-4.59%
Apr 1, 2024553.90M-2.24%
Mar 28, 2024566.60M9.30%
Mar 27, 2024518.40M5.17%
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Wave Life Sciences 569.84M
AnaptysBio 562.03M
Castle Biosciences 558.33M
Olema Pharmaceuticals 556.35M
IGM Biosciences 554.11M
GH Research 546.82M
ORIC Pharmaceuticals 543.72M
Phathom Pharmaceuticals 536.82M
Market Cap Rankings